Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend.


Journal

Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926

Informations de publication

Date de publication:
08 2022
Historique:
revised: 14 04 2022
received: 23 02 2022
accepted: 15 04 2022
pubmed: 7 5 2022
medline: 30 7 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

There is limited research exploring how smoking cessation treatment should be implemented into lung cancer screening in the United Kingdom. This study aimed to understand attitudes and preferences regarding the integration of smoking cessation support within lung cancer screening from the perspective of those eligible. Thirty-one lung cancer screening eligible individuals aged 55-80 years with current or former smoking histories were recruited using community outreach and social media. Two focus groups (three participants each) and 25 individual telephone interviews were conducted. Data were analysed using the framework approach to thematic analysis. Three themes were generated: (1) bringing lung cancer closer to home, where screening was viewed as providing an opportunity to motivate smoking cessation, depending on perceived personal risk and screening result; (2) a sensitive approach to cessation with the uptake of cessation support considered to be largely dependent on screening practitioners' communication style and expectations of stigma and (3) creating an equitable service that focuses on ease of access as a key determinant of uptake, where integrating cessation within the screening appointment may sustain increased quit motivation and prevent loss to follow-up. The integration of smoking cessation into lung cancer screening was viewed positively by those eligible to attend. Screening appointments providing personalized lung health information may increase cessation motivation. Services should proactively support participants with possible fatalistic views regarding risk and decreased cessation motivation upon receiving a good screening result. To increase engagement in cessation, services need to be person-centred. This study has included patient and public involvement throughout, including input regarding study design, research materials, recruitment strategies and research summaries.

Identifiants

pubmed: 35514094
doi: 10.1111/hex.13513
pmc: PMC9327806
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1703-1716

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIHR Manchester Biomedical Research Centre
ID : IS-BRC-1215-20007
Organisme : Cancer Research UK
ID : A27905
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.

Références

Health Expect. 2020 Apr;23(2):433-441
pubmed: 31961060
J Thorac Oncol. 2018 Aug;13(8):1062-1075
pubmed: 29800746
Health Expect. 2017 Aug;20(4):563-573
pubmed: 27397651
J Epidemiol Community Health. 2021 Oct;75(10):1001-1009
pubmed: 33883199
Thorax. 2016 Feb;71(2):161-70
pubmed: 26645413
Ann Transl Med. 2016 Apr;4(8):157
pubmed: 27195275
BMC Public Health. 2020 Oct 6;20(1):1512
pubmed: 33023537
BMJ Open. 2020 Sep 10;10(9):e037086
pubmed: 32912948
JAMA Intern Med. 2015 Sep;175(9):1530-7
pubmed: 26214612
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Lung Cancer. 2007 Apr;56(1):125-34
pubmed: 17196298
Curr Oncol. 2021 Mar 14;28(2):1197-1203
pubmed: 33799451
Transl Lung Cancer Res. 2021 Feb;10(2):1099-1109
pubmed: 33718048
CA Cancer J Clin. 2021 Jul;71(4):299-314
pubmed: 34015860
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Health Expect. 2022 Aug;25(4):1703-1716
pubmed: 35514094
J Cancer Educ. 2018 Oct;33(5):1120-1125
pubmed: 28405898
BMJ Open Respir Res. 2019 Nov 24;6(1):e000448
pubmed: 31803474
Nicotine Tob Res. 2020 Aug 24;22(9):1484-1491
pubmed: 31504798
J Thorac Oncol. 2011 Nov;6(11):1841-8
pubmed: 21892105
Br J Health Psychol. 2021 Dec 1;:
pubmed: 34852182
Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975
pubmed: 31825647
Ann Intern Med. 2021 Sep;174(9):1232-1239
pubmed: 34310171
Thorax. 2012 May;67(5):418-25
pubmed: 22106018
Lancet Oncol. 2017 Dec;18(12):e754-e766
pubmed: 29208441
Transl Behav Med. 2018 Mar 1;8(2):243-267
pubmed: 29447386
Thorax. 2020 Oct;75(10):908-912
pubmed: 32759387
BJGP Open. 2020 Aug 25;4(3):
pubmed: 32522753
Thorax. 2017 Oct;72(10):912-918
pubmed: 28710339
Cancer. 2022 May 15;128(10):1976-1986
pubmed: 35143041
Nicotine Tob Res. 2020 Aug 24;22(9):1476-1483
pubmed: 31418449
J Natl Cancer Inst. 2014 May 28;106(6):dju122
pubmed: 24872542
J Natl Cancer Inst. 2014 May 28;106(6):dju084
pubmed: 24872540
Lung Cancer. 2019 Apr;130:121-127
pubmed: 30885332
BMC Public Health. 2006 Dec 11;6:300
pubmed: 17156479
Nat Rev Clin Oncol. 2021 Mar;18(3):135-151
pubmed: 33046839
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Health Expect. 2018 Dec;21(6):1150-1158
pubmed: 30085384
BMJ Open. 2019 Nov 2;9(11):e032727
pubmed: 31678956
Nicotine Tob Res. 2020 Mar 16;22(3):431-439
pubmed: 30476209
Int J Environ Res Public Health. 2018 Feb 17;15(2):
pubmed: 29462994
Lung Cancer. 2020 Jan;139:41-46
pubmed: 31726252
Health Expect. 2017 Feb;20(1):59-68
pubmed: 26701339
Lancet Oncol. 2014 Nov;15(12):1342-50
pubmed: 25282284
PLoS One. 2013 Aug 07;8(8):e71379
pubmed: 23940744
BMC Health Serv Res. 2021 May 20;21(1):481
pubmed: 34016109
BMJ Open. 2019 May 22;9(5):e025902
pubmed: 31122972
Lung Cancer. 2019 Aug;134:66-71
pubmed: 31319997
J Thorac Oncol. 2021 Dec;16(12):2016-2028
pubmed: 34403828
Contemp Clin Trials. 2021 Jul;106:106429
pubmed: 33964415
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Lung Cancer. 2019 Feb;128:1-5
pubmed: 30642439
Public Health. 2021 May;194:216-222
pubmed: 33962099
Thorax. 2019 Apr;74(4):405-409
pubmed: 29440588
Health Expect. 2019 Apr;22(2):162-172
pubmed: 30289583
BMJ. 2017 Dec 28;359:j5742
pubmed: 29284594
BMJ Open Respir Res. 2022 Feb;9(1):
pubmed: 35121633
Chest. 2020 Sep;158(3):1250-1259
pubmed: 32304776
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
Thorax. 2019 Dec;74(12):1176-1178
pubmed: 31481631

Auteurs

Samantha Groves (S)

School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Grace McCutchan (G)

Wales Cancer Research Centre, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.

Samantha L Quaife (SL)

Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Rachael L Murray (RL)

Academic Unit of Lifespan and Population Health, Faculty of Medicine, University of Nottingham, Nottingham, UK.

Jamie S Ostroff (JS)

Memorial Sloan-Kettering Cancer Center, Behavioral Sciences Service, New York, New York, USA.

Kate Brain (K)

Wales Cancer Research Centre, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.

Philip A J Crosbie (PAJ)

LydiaBecker Institute of Immunology and Inflammation, Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Wythenshawe, UK.

Janelle Yorke (J)

School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Christie Patient-Centred Research, Division of Nursing, Midwifery and Social Work, The Christie NHS Foundation Trust, The University of Manchester, Manchester, UK.

David Baldwin (D)

Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.

John K Field (JK)

Institute of Systems, Molecular and Integrative Biology, Molecular and Clinical Cancer Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Lorna McWilliams (L)

School of Health Sciences, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH